Literature DB >> 2580809

Intravital fluorescence microscopy for the study of blood-brain-barrier function.

M Wahl, A Unterberg, A Baethmann.   

Abstract

Vascular diameters and blood-brain-barrier (BBB) function were investigated in the parietal cortex of cats using an open skull window technique and intravital fluorescence microscopy. The cortical surface was superfused with artificial cerebrospinal fluid containing: bradykinin (BK), Na+-arachidonate (AA), or xanthine-oxidase (XO). Na+-fluorescein (MW: 376), fluorescein-isothiocyanate-labelled (FITC) albumin (MW: 67 000), or FITC-dextran (MW: 19 400-62 000) were given intravenously as blood-brain-barrier indicators of different molecular size. In control experiments, the effect of continuous exposure of the preparation to the light source used for fluorescence excitation was studied. Dependent on the molecular size of the tracer and light intensity, continuous light exposure led to extravasation and disturbances of the microcirculation in small veins. When Na+-fluorescein was employed as barrier indicator at a magnification of X 40, at least 55 min of continuous illumination were required to induce extravasation. Brief, i.e. 0.5-15 s and discontinuous illumination for taking microphotographs amounting to less than 20 min in total did not induce extravasation in control experiments of 3.5 h. Opening of the blood-brain-barrier was studied during superfusion with a hypertonic solution (2000 mOsmol 1(-1)). The results obtained with bradykinin, Na+-arachidonate, or xanthine-oxidase indicate that opening of the barrier can occur independently from a corresponding vasodilating reaction. BK, or AA led to initial venular leakage as a result of an increase of selective, or global barrier permeability. On the other hand, XO did not induce extravasation, although cerebral vessels were markedly dilated. Taken together, the experimental model presented is suitable to simultaneously analyze dynamic changes of the permeability of cerebral vessels in-vivo with excellent spatial resolution and of the cerebral vasomotor behaviour under physiological and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580809

Source DB:  PubMed          Journal:  Int J Microcirc Clin Exp        ISSN: 0167-6865


  8 in total

1.  Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat.

Authors:  M H Sarker; D E Hu; P A Fraser
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

2.  Lack of effect of topically applied nicotine on pial arteriole diameter and blood-brain barrier integrity in the cat.

Authors:  L Schilling; A Bultmann; M Wahl
Journal:  Clin Investig       Date:  1992 Mar-Apr

3.  Computerised image analysis in conjunction with fluorescence microscopy for the study of blood-brain barrier permeability in vivo.

Authors:  A Findling; L Schilling; A Bultmann; M Wahl
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

4.  Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid.

Authors:  A Unterberg; M Wahl; F Hammersen; A Baethmann
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone.

Authors:  L Schürer; P Temesvari; M Wahl; A Unterberg; A Baethmann
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Effects of increased intracranial pressure in brain surface microcirculation in rats.

Authors:  S Kawamura; N Yasui
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Effects of free radicals on permeability and vasomotor response of cerebral vessels.

Authors:  A Unterberg; M Wahl; A Baethmann
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 8.  Contributions of the immune system to the pathophysiology of traumatic brain injury - evidence by intravital microscopy.

Authors:  Susanne M Schwarzmaier; Nikolaus Plesnila
Journal:  Front Cell Neurosci       Date:  2014-11-04       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.